Hem D Shukla (Hem Shukla)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Current pharmaceutical design

Cancers

Cell death discovery

International journal of radiation biology

Rani Durgavati University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Rani Durgavati University May 01 1994

India

PHD :: Department of Biological Sciences

Publications

Daniil Sokolov, Neha Sharda, Aindrila Banerjee, Kseniia Denisenko, Emad B Basalious, Hem D Shukla, Jaylyn Waddell, Nadia M Hamdy, Aditi Banerjee
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics. Current pharmaceutical design 30 (1) (2024)
Sanjit Roy, Tijana Dukic, Zachery Keepers, Binny Bhandary, Narottam Lamichhane, Jason Molitoris, Young H Ko, Aditi Banerjee, Hem D Shukla
SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids. Cell death discovery 10 (1) (2024)
Sanjit Roy, Tijana Dukic, Zachery Keepers, Binny Bhandary, Narottam Lamichhane, Jason Molitoris, Young H Ko, Aditi Banerjee, Hem D Shukla
SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids. Cell death discovery 10 (1) (2024)
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, Kseniia Denisenko, Emad B Basalious, Hem D Shukla, Jaylyn Waddell, Nadia M Hamdy, Aditi Banerjee
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics. Current pharmaceutical design 30 (1) (2024)
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, Kseniia Denisenko, Emad B Basalious, Hem D Shukla, Jaylyn Waddell, Nadia M Hamdy, Aditi Banerjee
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics. Current pharmaceutical design (2023)
Dominic Leiser, Santanu Samanta, John Eley, Joshua D Strauss, Michael Creed, Tami Kingsbury, Paul N Staats, Binny Bhandary, Minjie Chen, Tijana Dukic, Sanjit Roy, Javed Mahmood, Zeljko Vujaskovic, Hem D Shukla
Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer. PloS one 16 (11) (2021)
Prerna Singh, John Eley, Ali Saeed, Binny Bhandary, Nayab Mahmood, Minjie Chen, Tijana Dukic, Sina Mossahebi, Dario B Rodrigues, Javed Mahmood, Zeljko Vujaskovic, Hem D Shukla
Effect of hyperthermia and proton beam radiation as a novel approach in chordoma cells death and its clinical implication to treat chordoma. International journal of radiation biology 97 (12) (2021)
Javed Mahmood, Allen A Alexander, Santanu Samanta, Shriya Kamlapurkar, Prerna Singh, Ali Saeed, France Carrier, Xuefang Cao, Hem D Shukla, Zeljko Vujaskovic
A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of Mice. Cancers 12 (4) (2020)
Javed Mahmood, Hem D Shukla, Sandrine Soman, Santanu Samanta, Prerna Singh, Shriya Kamlapurkar, Ali Saeed, Neha P Amin, Zeljko Vujaskovic
Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment. Cancers 10 (12) (2018)
Hem D Shukla
Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer. Proteomes 5 (4) (2017)

Hem D Shukla.css-eqlu8i{font-size:small;padding-left:4px;} (Hem Shukla)

Publication Activity (10 Years)

Top Topics

Top Venues

Hem D Shukla (Hem Shukla)